Antipsychotic prescribing in dementia patients in care homes: Proactive in-reach service improved quality of care

International Journal of Geriatric Psychiatry

Volumn 27, Issue 10, 2012, Pages 1097-1098

  Chakraborty, Arpita ^a   Linton, Caroline Ruth ^a  

^a Grounds of St Cadoc's Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CEREBROVASCULAR DISEASE; DEATH; DEMENTIA; DRUG FATALITY; GERIATRIC CARE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HOME CARE; HUMAN; LETTER; NURSING HOME; PRESCRIPTION; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CLINICAL AUDIT; DEMENTIA; FEMALE; GUIDELINE ADHERENCE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; STATE MEDICINE; WALES;

EID: 84865857752     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2827     Document Type: Letter

References (3)

1. Great Britain Department of Health. 2009. The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services by Professor Sube Banerjee. London.
2. Great Britain House of Commons. 2008. Always a last resort: Inquiry into the prescription of antipsychotic drugs to people with dementia living in care homes. All-Party Parliamentary Group on Dementia: London.
3. National Institute for Health and Clinical Excellence. 2006. NICE Clinical Guideline 42 Dementia: Supporting People with Dementia and Their Carers in Health and Social Care. London: National Institute for Health and Clinical Excellence.